| Date Filed | Type | Description |
| 06/10/2020 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Unknown transaction of 60,121 shares
@ $0
Disposed/sold 34,000 options to buy
@ $6.78, valued at
$230.5k
Disposed/sold 24,000 options to buy
@ $8.2, valued at
$196.8k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 13,158 shares
@ $0 |
|
| 06/20/2017 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 24,000 options to buy
@ $8.2, valued at
$196.8k
|
|
| 05/26/2016 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 34,000 options to buy
@ $6.78, valued at
$230.5k
|
|
| 06/25/2015 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 24,000 options to buy
@ $12.76, valued at
$306.2k
|
|
| 09/04/2014 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Bought 1,000 shares
@ $11.1429, valued at
$11.1k
|
|
| 06/23/2014 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $14.93, valued at
$298.6k
|
|
| 06/21/2013 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $24.88, valued at
$497.6k
|
|
| 06/03/2013 |
4
| ZUERBLIS KENNETH J (Director) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Bought 600 shares
@ $15.8499, valued at
$9.5k
Bought 500 shares
@ $15.86, valued at
$7.9k
Bought 1,000 shares
@ $15.86, valued at
$15.9k
Bought 200 shares
@ $16.38, valued at
$3.3k
Bought 700 shares
@ $16.38, valued at
$11.5k
|
|
| 02/13/2012 |
4
| ZUERBLIS KENNETH J (EVP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.26, valued at
$226k
|
|
| 12/09/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2011 |
4
| ZUERBLIS KENNETH J (EVP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Bought 2,000 shares
@ $2.345, valued at
$4.7k
|
|
| 09/16/2011 |
4
| ZUERBLIS KENNETH J (EVP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Bought 1,000 shares
@ $3.97, valued at
$4k
Bought 4,000 shares
@ $4.0474, valued at
$16.2k
|
|
| 09/14/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 09/14/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2010 |
3
| ZUERBLIS KENNETH J (Director) has filed a Form 3 on IMMUNOMEDICS INC |
| 08/14/2003 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 08/13/2001 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 08/09/2000 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 08/14/1998 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 08/12/1997 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 03/01/1996 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |